Link Therapeutics
Link Therapeutics is a biotech company in Kyoto, Japan, founded in 2022. It has raised $7.1M across 3 rounds, most recently a $5.3M Series B in July 2025.
Link Therapeutics Top
- Headquarters
- Kyoto
- Founded
- 2022
- Business Model
- B2B
- Website
- link-therapeutics.com
- Total Funding
- $7.1M
- Last Round
- $5.3M Series BJul 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
Link Therapeutics develops therapeutic technologies for autoantibody-mediated diseases. Its approach focuses on eliminating pathogenic autoantibodies and the cells that produce them, alongside discovering pathogenic autoantibodies to support the development of treatments directed at these disease-causing antibodies.
Summary
It has raised $7.1M in total across 3 rounds, most recently a $5.3M Series B round in Jul 2025. Investors include Kyoto University Innovation Capital, Mitsubishi UFJ Financial and SMBC Venture Capital.
Funding History
Jul 2025
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/link-therapeutics"><img src="https://indexed.vc/api/badge/company/link-therapeutics" alt="Link Therapeutics on Indexed.vc" width="260" height="76" /></a>